+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioresorbable Bone-graft Substitute Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079308
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bioresorbable bone-graft substitutes are revolutionizing the field of orthopedic medicine by providing innovative solutions that support natural bone healing and minimize the need for secondary surgeries. These advanced materials are designed to gradually dissolve within the body, transferring load to regenerating bone tissue, and thereby ensuring a smooth transition from temporary support to permanent healing. As healthcare systems worldwide seek to improve patient outcomes, reduce procedural risks, and control costs, the advent of resorbable grafts addresses critical challenges associated with traditional grafting techniques, such as donor site morbidity and long-term implant complications.

In recent years, the research community and industry stakeholders have intensified their focus on the development of bioresorbable materials, driven by a deepening understanding of the biological mechanisms that govern bone regeneration and the increasing adoption of minimally invasive procedures. This introduction sets the stage for an in-depth examination of the transformative shifts shaping this market, the impact of evolving trade policies, key segmentation and regional insights, as well as actionable recommendations for industry leaders seeking to capitalize on emerging opportunities. By offering a detailed yet accessible overview, this report empowers decision-makers to navigate a rapidly evolving landscape with confidence and clarity.

Transformative Shifts Reshaping the Landscape

The bioresorbable bone-graft substitute market has undergone a fundamental metamorphosis over the past decade as material science breakthroughs and clinical demands have converged. Initially dominated by ceramic-based grafts prized for their osteoconductive properties, the market has expanded to embrace composite materials that combine the strength of ceramics with the flexibility of polymers. More recently, polymer-based substitutes-both natural and synthetic-have gained traction due to their tunable degradation rates and enhanced biocompatibility. This shift reflects a growing recognition that a one-size-fits-all approach cannot satisfy the diverse requirements of joint reconstruction, spinal fusion, and trauma repair.

Concurrently, the fabrication techniques used to produce these grafts have evolved from traditional molding processes to advanced additive manufacturing. Three-dimensional printing now allows for patient-specific implants with complex internal architectures that promote vascularization and cell ingrowth. Injection molding, on the other hand, remains invaluable for high-volume, cost-sensitive applications, ensuring that demand across hospitals and specialty clinics can be met without sacrifice to quality. This dynamic interplay between material innovation and manufacturing technology has set the stage for unprecedented clinical outcomes and operational efficiencies.

As practitioners increasingly embrace minimally invasive surgical procedures and outpatient care models, the requirements for graft substitutes continue to shift toward materials that offer rapid integration, predictable resorption profiles, and simplified handling. This ongoing transition underscores the importance of staying abreast of emerging trends, regulatory developments, and competitive dynamics. By understanding these transformative shifts, stakeholders can align their product strategies to meet evolving clinical needs and secure a leadership position in this burgeoning market.

Cumulative Impact of United States Tariffs Introduced in 2025

The imposition of new tariffs on medical devices and raw materials by the United States government in 2025 has introduced both challenges and opportunities for the bioresorbable graft substitute market. On the one hand, increased duties on imported ceramic powders and polymer feedstocks have elevated production costs for manufacturers relying on global supply chains. This has prompted several firms to reassess their procurement strategies, exploring nearshoring options and diversifying supplier portfolios to mitigate exposure to tariff volatility.

On the other hand, domestic suppliers of raw materials have seen heightened demand as manufacturers shift sourcing closer to home. This trend has stimulated investments in capacity expansion and quality enhancement, leading to improved lead times and more reliable supply for OEMs. Moreover, the tariffs have incentivized partnerships between material innovators and contract manufacturers within the United States, fostering joint ventures aimed at co-developing next-generation substitutes with optimized performance and cost attributes.

Despite the short-term pressures on pricing, the long-term effect of these trade measures may be to strengthen the resilience of the local manufacturing ecosystem. Companies that proactively adjust their sourcing and production footprints can not only shield themselves from tariff shocks but also leverage the narrative of onshoring to align with healthcare purchasers’ preference for domestically produced medical implants. Ultimately, the cumulative impact of the United States tariffs in 2025 will be measured by the extent to which industry participants can adapt their value chains to maintain competitive pricing while enhancing product availability and quality.

Key Segmentation Insights Across Material, Application, End-User, and Fabrication

Analysis of the market through the lens of material type reveals that ceramic-based substitutes maintain a strong foothold in applications requiring high compressive strength, such as spinal fusion and load-bearing joint reconstruction. Meanwhile, composite materials-blending ceramics with polymers-have carved out a niche where a balance between structural integrity and controlled resorption is paramount. Within the polymer-based category, natural polymers such as collagen and chitosan are highly regarded for their intrinsic bioactivity, while synthetic polymers like polylactic acid and polycaprolactone afford manufacturers precise control over degradation timelines and mechanical properties.

When considering application area, the distinct needs of joint reconstruction, spinal fusion, and trauma repair become apparent. Joint reconstruction continues to demand substitutes that can withstand cyclic loading over extended periods, driving interest in reinforced composites. Spinal fusion procedures benefit from materials that encourage rapid osteointegration to minimize non-union risks. In trauma repair, the divergence between non-surgical treatment and surgical procedures highlights the necessity for substitutes that can be delivered via minimally invasive methods and that support rapid bone bridging in acute fracture management.

End-user demographics further refine the landscape, as hospitals prioritize grafts with strong clinical track records and streamlined sterilization workflows, research laboratories explore novel formulations for next-generation scaffolds, and specialty clinics seek off-the-shelf solutions that reduce operating room time. Finally, the choice of fabrication technique can be decisive: three-dimensional printing is enabling bespoke implants tailored to patient anatomy, while injection molding remains the method of choice for cost-effective, large-volume production of standardized grafts. By integrating these segmentation insights, stakeholders can tailor their product development and commercialization strategies to address the distinct requirements of each market segment.

Key Regional Dynamics Influencing Market Direction

Geographic analysis reveals that the Americas region commands a mature market characterized by broad reimbursement coverage and extensive clinical adoption, particularly in the United States where regulatory pathways for novel bioresorbable materials have become more streamlined. Latin American markets, while smaller in absolute terms, show promise as improved healthcare infrastructure and rising orthopedic procedure rates drive demand for advanced graft substitutes.

The Europe, Middle East & Africa region presents a heterogeneous landscape. Western Europe leads in clinical trials and early adoption of high-end composite and polymer-based substitutes, supported by strong regulatory harmonization and funding for innovation. In contrast, markets in Eastern Europe and parts of the Middle East are gradually expanding capacity for advanced orthopedic procedures, although cost constraints and variable reimbursement frameworks temper growth. Across Africa, the focus remains on foundational access to essential grafting materials, but select markets are beginning to explore bioresorbable solutions for specialized trauma care.

Asia-Pacific stands out as a high-growth frontier, driven by rapid urbanization, increasing healthcare expenditures, and a growing prevalence of degenerative bone disorders. Countries such as Japan and South Korea have well-established research and development ecosystems that accelerate the commercialization of advanced materials, while China and India are investing heavily in domestic manufacturing capabilities to meet surging demand. This combination of innovation and scale positions the region as a pivotal battleground for market share among leading global and local players.

Leading Company Strategies and Innovations

The competitive environment is anchored by several major players that have shaped the evolution of resorbable bone-graft substitutes. DePuy Synthes Companies has leveraged its extensive orthopedic portfolio to integrate resorbable offerings that complement its fixation systems, deploying a strategy that emphasizes surgeon training and clinical evidence generation. Medtronic plc stands out for its investments in biomaterials research, particularly in the development of polymer blends that optimize degradation profiles for spinal applications.

Stryker Corporation has introduced a range of composite granules and putties designed for ease of use in trauma and minimally invasive procedures, with an emphasis on streamlined packaging and intraoperative adaptability. Zimmer Biomet has strengthened its position through strategic acquisitions and partnerships, securing access to emerging polymer technologies and 3D printing capabilities that enable patient-specific implant solutions. Collectively, these companies are driving the market forward through a combination of R&D commitment, channel expansion, and clinical collaborations, setting a high bar for innovation and market execution.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize the development of adaptable material platforms that can be customized to meet diverse clinical requirements across joint reconstruction, spinal fusion, and trauma repair. By establishing modular product families that accommodate variations in mechanical strength, resorption rate, and handling characteristics, companies can streamline their R&D pipelines and accelerate time to market.

Furthermore, investing in scalable manufacturing processes that balance three-dimensional printing for bespoke applications with injection molding for high-volume production will be critical. Partnerships with contract manufacturers and material suppliers can mitigate capital expenditure risks while ensuring access to cutting-edge technologies. Synchronizing these efforts with robust clinical evidence programs will bolster reimbursement support and facilitate clinician adoption.

Stakeholders should also engage proactively with regulatory agencies to shape favorable review frameworks for novel bioresorbable constructs, leveraging real-world data to validate safety and efficacy. Finally, strengthening ties with healthcare providers through comprehensive training initiatives and digital support tools will enhance surgeon confidence, reduce procedural variability, and drive preference generation.

Conclusion: Navigating Opportunities in a Dynamic Market

The landscape for bioresorbable bone-graft substitutes is characterized by rapid innovation, evolving clinical demands, and shifting trade policies. Companies that adeptly navigate material selection, fabrication technologies, and regulatory pathways will unlock new opportunities to improve patient outcomes and drive sustainable growth. By embracing modular design principles, optimizing supply chains in response to tariff impacts, and forging strategic partnerships across the value chain, stakeholders can secure competitive advantage and shape the future of orthopedic care.

As the market continues to mature, success will hinge on the ability to deliver clinically differentiated solutions at competitive cost points, supported by compelling evidence and strong post-market surveillance. Firms that align their product portfolios with the specific needs of hospitals, specialty clinics, and research institutions, while maintaining agility in manufacturing and distribution, will emerge as the dominant forces in this dynamic sector.

Market Segmentation & Coverage

This research report categorizes the Bioresorbable Bone-graft Substitute Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Ceramic-Based
  • Composite Materials
  • Polymer-Based
    • Natural Polymer
    • Synthetic Polymer
  • Joint Reconstruction
  • Spinal Fusion
  • Trauma Repair
    • Non-Surgical Treatment
    • Surgical Procedures
  • Hospitals
  • Research Laboratories
  • Specialty Clinics
  • 3D Printing
  • Injection Molding

This research report categorizes the Bioresorbable Bone-graft Substitute Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioresorbable Bone-graft Substitute Market to delves into recent significant developments and analyze trends in each of the following companies:

  • DePuy Synthes Companies
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioresorbable Bone-graft Substitute Market, by Material Type
8.1. Introduction
8.2. Ceramic-Based
8.3. Composite Materials
8.4. Polymer-Based
8.4.1. Natural Polymer
8.4.2. Synthetic Polymer
9. Bioresorbable Bone-graft Substitute Market, by Application Area
9.1. Introduction
9.2. Joint Reconstruction
9.3. Spinal Fusion
9.4. Trauma Repair
9.4.1. Non-Surgical Treatment
9.4.2. Surgical Procedures
10. Bioresorbable Bone-graft Substitute Market, by End-User Demographics
10.1. Introduction
10.2. Hospitals
10.3. Research Laboratories
10.4. Specialty Clinics
11. Bioresorbable Bone-graft Substitute Market, by Technique of Fabrication
11.1. Introduction
11.2. 3D Printing
11.3. Injection Molding
12. Americas Bioresorbable Bone-graft Substitute Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Bioresorbable Bone-graft Substitute Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Bioresorbable Bone-graft Substitute Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. DePuy Synthes Companies
15.3.2. Medtronic plc
15.3.3. Stryker Corporation
15.3.4. Zimmer Biomet
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET MULTI-CURRENCY
FIGURE 2. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET MULTI-LANGUAGE
FIGURE 3. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY CERAMIC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY NON-SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 78. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 80. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 81. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 82. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 83. CHINA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 84. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 86. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 87. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 88. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 89. INDIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 96. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 98. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 99. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 100. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 132. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 134. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 135. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 136. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 157. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 163. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 205. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 211. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 212. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 213. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 214. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 215. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 216. POLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 217. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 241. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY END-USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SIZE, BY TECHNIQUE OF FABRICATION, 2018-2030 (USD MILLION)
TABLE 277. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. BIORESORBABLE BONE-GRAFT SUBSTITUTE MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

  • DePuy Synthes Companies
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet

Methodology

Loading
LOADING...